Pre-CAAP Company: Tieos Pharmaceuticals Makes it to Finals of the 2017 BioInnovation Challenge
Tieös Pharmaceuticals, a next-generation biotech company focused on cancer metabolic therapies, was selected as a finalist in the 2017 BioInnovation Challenge being held in Halifax, Nova Scotia.
“We are honored to be finalists in the 2017 BioInnovation Challenge and look forward to further expanding our presence in Atlantic Canada. We also feel that this is an opportune time for Tieös to emerge from stealth mode and into the public scene as we move forward to an exciting phase in our drug development process.”
Read the full press release from Tieos here